A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells

Cited by (508)

Items 301–400 of 508

1. Manipulating cell fate through reprogramming: approaches and applications.
   Masaki Yagi, Joy E. Horng, K. Hochedlinger · 2024 · Development
2. Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
   Chul-Kyu Kim, P. Sachdev, N. Braidy · 2022 · Aging and Disease
3. RNA-Based Strategies for Cell Reprogramming toward Pluripotency
   Anaëlle Bailly, O. Milhavet, Jean-Marc Lemaître · 2022 · Pharmaceutics
4. Current status and future prospects of patient-derived induced pluripotent stem cells
   Zhiqiang Wang, Jing Zheng, Ruolang Pan, Ye Chen · 2021 · Human Cell
5. Leucine‐Rich Repeat Neuronal Protein 1 Regulates Differentiation of Embryonic Stem Cells by Post‐Translational Modifications of Pluripotency Factors
   Chien-Huang Liao, Ya-Hui Wang, Wei-Wei Chang, Bei-Chia Yang, Tsai-Jung Wu, Wei-Li Liu, A. L. Yu, John Yu · 2018 · Stem Cells
6. Advances and applications of induced pluripotent stem cells
   Stefano Pietronave, María Prat · 2012 · Canadian Journal of Physiology and Pharmacology
7. Strategies for future histocompatible stem cell therapy
   Jan Olof Nehlin, Torben Barington · 2009 · Biogerontology
8. Epigenetic memory as crucial contributing factor in directing the differentiation of human iPSC into pancreatic β-cells in vitro
   Abdoulaye Diane, Razik Bin Abdul Mu-U-Min, H. Al-Siddiqi · 2025 · Cell and Tissue Research
9. The occurrence and development of induced pluripotent stem cells
   Yi Chen, Meng Li, Y. Wu · 2024 · Frontiers in Genetics
10. The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling
    A. Sadasivam Devendran, Sumanta Kar, Rasheed A. Bailey, Maria Giovanna Trivieri · 2022 · Cells
11. Reprogramming progressive cells display low CAG promoter activity
    Xiao Hu, Qiao Wu, Jian Zhang, Jonghun Kim, Xinyue Chen, Amaleah A. Hartman, Anna E. Eastman, In‐Hyun Park, Shangqin Guo · 2020 · Stem Cells
12. Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation.
    H. Habisch, S. Liebau, T. Lenk, A. Ludolph, R. Brenner, A. Storch · 2010 · Cytotherapy
13. Challenges of therapeutic applications and regenerative capacities of urine based stem cells in oral, and maxillofacial reconstruction.
    Gamal A. Atia, Fatema Rashed, Ehab S. Taher, Ssang-goo Cho, A. A. Dayem, Magdalen M. Soliman, Hany K. Shalaby, Nourelhuda A. Mohammed, Noha Taymour, Mohamed El-Sherbiny et al. · 2024 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
14. Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models
    Ying Zhang, Xinyang Xie, Jiangnan Hu, Kazi Sabrina Afreen, Chun‐Li Zhang, Qichuan Zhuge, Jianjing Yang · 2020 · Frontiers in Neuroscience
15. Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts.
    Jia-Li Pu, Ting Gao, R. Zheng, Yi Fang, Yang Ruan, Chong-yao Jin, Ting Shen, Jun Tian, Baorong Zhang · 2020 · Brain Research Bulletin
16. Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension
    Nobutoshi Nawa, Hidekazu Ishida, S. Katsuragi, Hiroki Baden, Kunihiko Takahashi, Ryota Higeno, Fumiko Torigoe, Seiko Mihara, J. Narita, Kohji Miura et al. · 2016 · Molecular Therapy: Methods & Clinical Development
17. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    P. Guillot · 2016 · Best Practice & Research: Clinical Obstetrics & Gynaecology
18. Finding degrees of separation: Experimental approaches for astroglial and oligodendroglial cell isolation and genetic targeting
    Li‐Jin Chew, Cynthia A. DeBoy, Vladimir V. Senatorov · 2014 · Journal of Neuroscience Methods
19. Induced pluripotent stem cells for modeling of pediatric neurological disorders
    Jiho Jang, Zhejiu Quan, Yunjin J. Yum, Hyo Sook Song, Seonyeol Paek, Hoon‐Chul Kang · 2014 · Biotechnology Journal
20. iPS cells generation: an overview of techniques and methods
    S. Telpalo-Carpio, J. M. Aguilar-Yáñez, María Teresa González-Garza, Delia E. Cruz-Vega, Jorge E. Moreno-Cuevas · 2013 · Journal of Stem Cells and Regenerative Medicine
21. Standardization of human stem cell pluripotency using bioinformatics
    Michael W. Nestor, S. Noggle · 2013 · Stem cell research & therapeutics
22. Reprogramming resistant genes: in-depth comparison of gene expressions among iPS, ES, and somatic cells
    Natalia Polouliakh · 2012 · Front. Physio.
23. Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology
    Vassiliki Nikoletopoulou, Nektarios Tavernarakis · 2012 · Biotechnology Journal
24. The iPS Technique Provides Hope for Parkinson’s Disease Treatment
    Liang-Liang Xu, Yuyan Tan, Jian-Qing Ding, Sheng-Di Chen · 2010 · Stem Cell Reviews and Reports
25. Natural and artificial routes to pluripotency
    Winfried H. Krueger, Lindsey C. Swanson, Borko Tanasijevic, Theodore P. Rasmussen · 2010 · The International Journal of Developmental Biology
26. Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines
    Eglė Strainienė, Mindaugas Binkis, Silvija Urnikytė, V. Stankevičius, Ausra Sasnauskiene, Gabrielis Kundrotas, A. Kazlauskas, K. Sužiedėlis · 2018 · BMC Cancer
27. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
    E. Poursani, Majid Mehravar, B. Soltani, S. Mowla · 2017 · Gene
28. Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells
    Zuojun Tian, Fuzheng Guo, Sangita Biswas, Wenbin Deng · 2016 · International Journal of Molecular Sciences
29. Induced pluripotent stem cells: From derivation to application in biochemical and biomedical research
    Ekaterina V. Novosadova, Igor A. Grivennikov · 2014 · Biochemistry (Moscow)
30. Differential Coupling of Self-Renewal Signaling Pathways in Murine Induced Pluripotent Stem Cells
    L. Orlando, Y. Sanchez-Ripoll, J. Foster, H. Bone, C. Giachino, M. Welham · 2012 · PLoS ONE
31. Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges
    Andrei Greșiță, D. Hermann, I. K. Boboc, T. Doeppner, Eugen Petcu, Ghinea Flavia Semida, Aurel Popa-Wagner · 2025 · Translational Stroke Research
32. Decellularized extracellular matrix microparticles as a vehicle for cellular delivery in a model of anastomosis healing.
    David M. Hoganson, Gwen E. Owens, A. Meppelink, Erik K. Bassett, Chris M. Bowley, Cameron J. Hinkel, Eric B. Finkelstein, S. Goldman, J. Vacanti · 2016 · Journal of Biomedical Materials Research. Part A
33. In vivo reprogramming in inflammatory bowel disease
    A. Wagnerová, R. Gardlík · 2013 · Gene Therapy
34. Current Methods for Inducing Pluripotency in Somatic Cells
    G. Tavernier, Barbara Mlody, J. Demeester, J. Adjaye, S. De Smedt · 2013 · Advances in Materials
35. EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours
    Sol Kim, Bobae Lim, J. Kim · 2010 · British Journal of Cancer
36. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming
    Ashlin Kanawaty, Jeffrey T. Henderson · 2009 · Bioessays
37. Modeling brain and neural crest neoplasms with human pluripotent stem cells
    Cedar Schloo, L. Kutscher · 2023 · Neuro-Oncology
38. Transcription Factors and Epigenetic Modulation: Its Therapeutic Implication in Chronic Kidney Disease
    K. Hayashi, H. Itoh · 2015 · Archivum Immunologiae et Therapiae Experimentalis
39. GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells
    Jaber Firas, Xiaodong Liu, Christian Maximilian Nefzger, Jose Maria Polo · 2014 · Differentiation
40. Secondary cell reprogramming systems: as years go by.
    A. Nagy · 2013 · Current Opinion in Genetics and Development
41. Cardiomyocyte reprogramming and the new age of cellular alchemy.
    Kenneth R. Chien, B. A. Yi, Huansheng Xu, C. Mummery · 2012 · Journal of Molecular and Cellular Cardiology
42. Concise Review: Non‐cell Autonomous Reprogramming: A Nucleic Acid‐Free Approach to Induction of Pluripotency
    Sowmya Parameswaran, S. Balasubramanian, Mahendra S. Rao, I. Ahmad · 2011 · Stem Cells
43. Looking into the Black Box: Insights into the Mechanisms of Somatic Cell Reprogramming
    L. David, P. Samavarchi-Tehrani, Azadeh Golipour, J. Wrana · 2011 · Genes
44. Nonintegrating Human Somatic Cell Reprogramming Methods.
    T. Schlaeger · 2018 · Advances in Biochemical Engineering/Biotechnology
45. Induced Pluripotent Stem Cells (iPSCs)
    S. Yıldırım · 2012 · SpringerBriefs in stem cells
46. AP-1 activity is a major barrier of human somatic cell reprogramming
    Liu, Yuting, He, Jiangping, Chen, Ruhai, Liu, He, Chen, Jocelyn, Liu, Yujian, Wang, Bo, Guo, Lin, Pei, Duanqing, Wang, Jie et al. · 2021 · Cellular and Molecular Life Sciences
47. Model systems to study tumor-microbiome interactions in early-onset colorectal cancer
    Katharina Maria Richter, Marius Wrage, Carolin Krekeler, Tiago De Oliveira, Lena‐Christin Conradi, Kerstin Menck, Annalen Bleckmann · 2025 · EMBO Molecular Medicine
48. Aberrant neuronal connectivity and network activity of neurons derived from patients with idiopathic schizophrenia.
    Johanna Heider, Emilio Pardo González, Sophia-Marie Hartmann, N. Kannaiyan, Sabrina Vogel, Richard Wüst, Andreas J. Fallgatter, M. Rossner, U. Kraushaar, H. Volkmer · 2024 · Neurobiology of Disease
49. Critical role of the fibroblast growth factor signalling pathway in Ewing's sarcoma octamer‐binding transcription factor 4‐mediated cell proliferation and tumorigenesis
    Jungho Kim, H. Kim, Jung‐Jae Shim, Jungwoon Lee, A. Kim, Jungho Kim · 2019 · The FEBS Journal
50. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.
    T. Rasmussen · 2019 · Seminars in Cancer Biology
51. Homogeneous generation of iDA neurons with high similarity to bona fide DA neurons using a drug inducible system.
    Hanseul Park, Hongwon Kim, Junsang Yoo, J. Lee, Hwan Choi, Soonbong Baek, C. J. Lee, Janghwan Kim, C. Lengner, Jung-Suk Sung et al. · 2015 · Biomaterials
52. Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells
    Huijun Shi, Q. Fu, Guozhong Li, Yan Ren, Sheng-Wei Hu, Wei Ni, F. Guo, Meng-Ting Shi, Luping Meng, Hui Zhang et al. · 2015 · Cellular Reprogramming
53. Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
    Christian Berens, Stephanie Bisle, Leonie Klingenbeck, Anja Lührmann · 2015 · Journal of Visualized Experiments
54. Molecular mechanisms of induced pluripotency
    K. Kulcenty, J. Wróblewska, Sylwia Mazurek, E. Liszewska, J. Jaworski · 2015 · Contemporary oncology
55. Co-regulation of pluripotency and genetic integrity at the genomic level
    Daniel J. Cooper, Christi A. Walter, John Robert McCarrey · 2014 · Stem Cell Research
56. Tissue Engineering of the Intervertebral Disc
    R. Kandel, P. Santerre, E. Massicotte, M. Hurtig · 2014 · Springer eBooks
57. Generation of iPS Cells from Human Umbilical Vein Endothelial Cells by Lentiviral Transduction and Their Differentiation to Neuronal Lineage
    M. Shutova, I. V. Chestkov, A. Bogomazova, M. Lagarkova, S. Kiselev · 2011
58. Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
    Chandan K. Sen, Andrew J. Friday, Sashwati Roy · 2025 · Pharmacological Reviews
59. Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to Pluripotency
    Simón Vidal, A. Polyzos, K. Chatterjee, Ly-sha Ee, E. Swanzey, Jorge Morales-Valencia, Hong-Su Wang, Chaitanya N Parikh, Bhishma Amlani, S. Tu et al. · 2020 · Stem Cell Reports
60. A “Hit and Run” Approach to Inducible Direct Reprogramming of Astrocytes to Neural Stem Cells
    M. Poulou, N. Mandalos, Theodoros Karnavas, M. Saridaki, R. Mckay, E. Remboutsika · 2016 · Frontiers in Physiology
61. Hydrogels as feeder‐free scaffolds for long‐term self‐renewal of mouse induced pluripotent stem cells
    Jing-Jing Yang, Jian-Fang Liu, T. Kurokawa, Kazuhiro Kitada, Jian-Ping Gong · 2015 · Journal of Tissue Engineering and Regenerative Medicine
62. Stem cell reprogramming: Basic implications and future perspective for movement disorders
    B. Brändl, S. Schneider, J. Loring, J. Hardy, P. Gribbon, Franz-Josef Müller · 2015 · Movement Disorders
63. Reprogramming rat embryonic fibroblasts into induced pluripotent stem cells using transposon vectors and their chondrogenic differentiation in vitro.
    Jiakuan Ye, Junyi Hong, Fusheng Ye · 2015 · Molecular Medicine Reports
64. Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
    Yi Cai, Steven Kregel, D. V. Vander Griend · 2013 · Journal of Visualized Experiments
65. Embryonic and Induced Pluripotent Stem Cells as a Model for Liver Disease
    Hiroshi Yagi, Edgar N. Tafaleng, Masaki Nagaya, Marc C. Hansel, Stephen C. Strom, Ira J. Fox, Alejandro Soto–Gutiérrez · 2009 · Critical Reviews in Biomedical Engineering
66. Systematic Evaluation of Extracellular Coating Matrix on the Differentiation of Human-Induced Pluripotent Stem Cells to Cortical Neurons
    Siyao Li, Yan Liu, Xianyang Luo, Wei Hong · 2024 · International Journal of Molecular Sciences
67. Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree
    C. Osterburg, M. Ferniani, D. Antonini, Ann-Sophie Frombach, Ludovica D'Auria, Susanne Osterburg, Rebecca Lotz, F. Löhr, S. Kehrloesser, H. Zhou et al. · 2023 · Cell Death and Disease
68. Retrospective identification of intrinsic factors that mark pluripotency potential in rare somatic cells
    N. Jain, Yogesh Goyal, Margaret C. Dunagin, Christopher J. Cote, Ian A. Mellis, Benjamin L. Emert, Connie L. Jiang, Ian P. Dardani, Sam Reffsin, A. Raj · 2023 · bioRxiv
69. Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications.
    S. Eminli, Baraa Kwieder, Kevin J. Yi, Christopher J. Z. Huang, J. Moon, C.-Hong Chang, Fedir N. Kiskin, N. Morrell, Brad Hamilton, A. Rana · 2021 · New Biotechnology
70. Urine-Derived Induced Pluripotent Stem Cells in Cardiovascular Disease
    Ping Huang, Yi-Bin Li, M. Nasser, Hui-Ming Guo, Huanlei Huang, Ming-Yi Zhao, P. Zhu · 2020 · Cardiology Research and Practice
71. Nystagmus‐related FRMD7 gene influences the maturation and complexities of neuronal processes in human neurons
    Jia-Li Pu, Shao-bing Dai, Ting Gao, Jing Hu, Yi Fang, R. Zheng, Chong-yao Jin, Baorong Zhang · 2019 · Brain and Behavior
72. Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes
    Katherine Sattler, I. El-Battrawy, Zhi-Han Zhao, Christoph Schrottenberg, Gökhan Yücel, H. Lan, Xin Li, S. Lang, W. Zimmermann, Lukas Cyganek et al. · 2019 · Scientific Reports
73. From skin to other cell types of the body
    Daniel Novák, Kasia Weina, J. Utikal · 2014 · Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
74. Adherens Junction Formation Inhibits Lentivirus Entry and Gene Transfer
    Roshan M Padmashali, Hui You, Nikhila Karnik, P. Lei, S. Andreadis · 2013 · PLoS ONE
75. Human ESC/iPSC-based “Omics” and Bioinformatics for Translational Research
    Gerd A. Müller, K. Tarasov, Rebekah L. Gundry, K. Boheler · 2012 · Drug Discovery Today : Disease Models
76. The Art of Human Induced Pluripotent Stem Cells: The Past, the Present and the Future
    Xiaogang Zhang, Alejandro De Los Angeles, Jinqiu Zhang · 2010 · The Open Stem Cell Journal
77. Investigating the Potential of Genes Preferentially Expressed in Oocyte to Induce Chromatin Remodeling in Somatic Cells
    Eve-Lyne Sylvestre, S. Pennetier, Mariève Bureau, C. Robert, M. Sirard · 2010 · Cellular Reprogramming
78. Les cellules souches pluripotentes induites
    D. Germain · 2009 · Pathologie Biologie
79. Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity
    Shi-Qi Li, Yichen Wang, Su-Meng Li, Yaxin Zhu, Yan-qin Du, Xin Zheng, Jun Wu · 2025 · Stem cell research & therapeutics
80. Generation of hiPSC-derived brain microvascular endothelial cells using a combination of directed differentiation and transcriptional reprogramming strategies
    Ao-Meng Cui, Ronak Patel, Patrick Bosco, U. Akcan, Emily Richters, Paula Delgado, D. Agalliu, Andrew A. Sproul · 2024 · bioRxiv
81. Reliable multiplex generation of pooled induced pluripotent stem cells
    Molly Smullen, Meagan N. Olson, Julia M. Reichert, Pepper Dawes, Liam F. Murray, C. Baer, Qi Wang, B. Readhead, G. Church, Elaine T. Lim et al. · 2023 · Cell Reports Methods
82. Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease
    Roberta Facioli, F. Lojudice, A. C. Anauate, E. Maquigussa, J. L. Nishiura, I. Heilberg, M. Sogayar, M. Boim · 2021 · PLoS ONE
83. Endothelial Differentiation G Protein‐Coupled Receptor 5 Plays an Important Role in Induction and Maintenance of Pluripotency
    I. Neganova, Lewis Cotts, P. Banks, Katja Gassner, A. Shukurov, L. Armstrong, G. Ladds, M. Lako · 2018 · Stem Cells
84. Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism
    Sabine Jung‐Klawitter, Thomas Opladen · 2018 · Journal of Inherited Metabolic Disease
85. Impaired Neural Differentiation Potency by Retinoic Acid Receptor-α Pathway Defect in Induced Pluripotent Stem Cells
    Pei-Shan Hou, Wen-Chin Huang, Wei Chiang, Wei-Che Lin, Chung-Liang Chien · 2014 · Cellular Reprogramming
86. Pluripotent Stem Cells to Model Human Cardiac Diseases
    Calvin C., Charles C. · 2013 · InTech eBooks
87. Development Unchained: How Cellular Reprogramming is Redefining Our View of Cell Fate and Identity
    Jem A. Efe, Xu Yuan, Kai Jiang, Sheng Ding · 2011 · Science in progress
88. Epidermal cells rev up reprogramming
    P. Gadue, G. Cotsarelis · 2008 · Nature Biotechnology
89. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer’s Disease
    Rebecca Atkinson-Dell, Lisa Mohamet · 2019 · Advances in experimental medicine and biology
90. Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application
    Monica Jara Avaca, Ina Gruh · 2017 · Advances in biochemical engineering, biotechnology
91. Induction of pluripotency.
    Corey Heffernan, Jun Liu, H. Sumer, L. Malaver-Ortega, R. Verma, Edmund Carvalho, P. Verma · 2013 · Advances in Experimental Medicine and Biology
92. Advances in Induced Pluripotent Stem Cell Reprogramming and Its Application in Amyotrophic Lateral Sclerosis: A Review
    Ying-Liu Luo, Zhenru Xu, Zunxiong Li · 2025 · FASEB bioAdvances
93. Utilizing induced neural stem cell‐based delivery of a cytokine cocktail to enhance chimeric antigen receptor‐modified T‐cell therapy for brain cancer
    Alex S. Woodell, Elisa Landoni, A. Valdivia, Andrew A. Buckley, Edikan A. Ogunnaike, G. Dotti, S. Hingtgen · 2023 · Bioengineering & Translational Medicine
94. Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages
    Celeste K Carberry, S. Ferguson, Adriana S. Beltrán, R. Fry, J. Rager · 2022 · Toxicology in Vitro
95. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.
    Kosuke Saito, N. Fukuda, K. Shinohara, Y. Masuhiro, S. Hanazawa, H. Matsuda, K. Fujiwara, T. Ueno, M. Soma · 2015 · International Journal of Biochemistry and Cell Biology
96. Differences in the Gene Expression Profiles of Slow- and Fast-Forming Preinduced Pluripotent Stem Cell Colonies
    Sujin Kwon, J. Park, Byungkuk Min, Yong-Kook Kang · 2015 · Stem Cells International
97. Progress and bottleneck in induced pluripotency
    Zhen-Ning Zhang, Yang Xu · 2012 · Cell Regeneration
98. Cardiomyocyte generation using stem cells and directly reprogrammed cells.
    M. Ieda, K. Fukuda · 2012 · Frontiers in Bioscience
99. Induced Pluripotent Stem Cells(iPS Cells):Current Status and Future Prospect*: Induced Pluripotent Stem Cells(iPS Cells):Current Status and Future Prospect*
    Hong-Fen Shen, Zhi-Guang Yao, Gao-Fang Xiao, Jun-Shuang Jia, D. Xiao, K. Yao · 2009 · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
100. Nuclear Reprogramming and Stem Cells
     J. Ainscough, 伸弥 山中, 高 多田 · 2012 · Stem Cell Biology and Regenerative Medicine